Cite
HARVARD Citation
Kurmasheva, R. et al. (2017). Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. Pediatric blood & cancer. 64 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kurmasheva, R. et al. (2017). Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. Pediatric blood & cancer. 64 (3), p. n/a. [Online].